Pharmaceuticals - Cameroon

Cameroon

Cameroon is projected to see a significant increase in revenue within the Pharmaceuticals market, with a projected amount of US$149.50m in 2024.
among the various markets within the market, Oncology Drugs is expected to be the largest, with a projected market volume of US$24.91m in 2024.
This indicates a strong demand for oncology drugs within the country.
Looking ahead, the revenue in the Pharmaceuticals market is expected to grow at an annual growth rate of 5.33% from 2024 to 2028.
This growth rate suggests a positive trajectory for the market, resulting in a projected market volume of US$184.00m by 2028.
In terms of global comparison, it is worth noting that United States is expected to generate the highest revenue within the Pharmaceuticals market, with a projected amount of US$636.90bn in 2024.
This highlights the strong presence and dominance of the United States in the global pharmaceutical industry.
Cameroon's pharmaceutical market is experiencing a surge in demand for locally produced herbal medicines.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Cameroon has been experiencing steady growth in recent years.

Customer preferences: Cameroon has a growing population, and with that comes an increasing demand for healthcare services and pharmaceuticals. Customers in Cameroon prefer affordable and easily accessible medicines. They also tend to favor generic drugs over branded ones due to their lower prices.

Trends in the market: One notable trend in the Pharmaceuticals market in Cameroon is the growing presence of multinational pharmaceutical companies. These companies are investing in the country and partnering with local firms to expand their market share. Additionally, there has been a rise in the production of generic drugs in the country, which has helped to lower the cost of medication for consumers.

Local special circumstances: Cameroon's healthcare system is still developing, and as a result, access to healthcare services and medication can be challenging in some areas. The government has been working to improve the healthcare infrastructure in the country, but progress has been slow. Additionally, there are still issues with counterfeit drugs in the market, which can be a significant concern for consumers.

Underlying macroeconomic factors: Cameroon's economy has been growing steadily, which has helped to drive demand for pharmaceuticals. The government has also been investing in the healthcare sector, which has helped to improve access to healthcare services for the population. However, there are still challenges in the market, including a lack of regulation and infrastructure, which can make it difficult for companies to operate in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.